Close



Apr 5, 2024 11:30PM
Mar 15, 2024 03:16PM
Mar 15, 2024 03:15PM
Mar 14, 2024 07:43AM
Mar 13, 2024 12:10PM
Mar 12, 2024 08:15AM
Mar 11, 2024 07:00AM Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights
Feb 23, 2024 07:15AM
Feb 23, 2024 07:15AM
Jan 12, 2024 10:28AM
Jan 4, 2024 03:55AM
Dec 24, 2023 09:15PM
Dec 21, 2023 05:42PM
Dec 14, 2023 07:34AM Titans Gather, Future Embarks: The GenScript Biotech Global Forum coinciding with the 2024 J.P. Morgan Healthcare Conference in San Francisco to Convene 20+ KOLs, Exploring Disruptive Transformations
Nov 13, 2023 08:31AM
Nov 13, 2023 08:30AM
Aug 15, 2023 06:00AM
Jun 6, 2023 04:31PM
Jun 6, 2023 04:30PM
Jun 5, 2023 11:04AM
May 29, 2023 08:03AM CELL WORLD - Aiming at Internationalization, Starting from Regulation - The 1st Global Cell Therapy Summit and Hillgene Biopharma Anniversary Celebration Successfully Held
May 25, 2023 08:32AM
May 25, 2023 08:30AM
May 18, 2023 08:30AM
May 16, 2023 08:35AM
Mar 30, 2023 08:40PM
Mar 30, 2023 04:01PM
Mar 7, 2023 10:35AM Venatorx Pharmaceuticals Appoints Tomas J. Heyman as Non-Executive Chairman
Jan 27, 2023 08:32AM
Jan 27, 2023 08:32AM
Jan 2, 2023 05:47AM
Jan 2, 2023 04:45AM
Nov 21, 2022 08:31AM
Nov 21, 2022 08:30AM
Nov 3, 2022 04:01PM Legend Biotech Shares Updated Data from Comprehensive Cilta-Cel Clinical Development Program at ASH 2022
Sep 27, 2022 09:09AM
Sep 27, 2022 09:09AM
Aug 31, 2022 08:45AM
Aug 5, 2022 08:30AM
Jul 12, 2022 08:00AM
Jun 4, 2022 01:40PM
Jun 4, 2022 09:00AM Longer-Term Data from CARTITUDE Program Continue to Show Deep and Durable Responses with Ciltacabtagene Autoleucel Across Lines of Therapy in Patients with Multiple Myeloma
Jun 3, 2022 08:31AM
Jun 3, 2022 08:30AM
Jun 1, 2022 08:30AM
May 31, 2022 04:01PM
May 26, 2022 05:38AM
May 26, 2022 03:10AM
May 18, 2022 08:30AM Legend Biotech to Highlight Continued Progress in the Treatment of Multiple Myeloma With Updated Data From BCMA CAR-T Studies at 2022 ASCO and EHA
May 17, 2022 09:00AM

251,403 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All